Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research  (CIHR)
Not yet recruiting - verified June 2015

NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial

Conditions:   Radiographic Contrast Agent Nephropathy;   Pulmonary Embolism
Interventions:   Drug: NAC;   Drug: NaHCO3;   Drug: Normal Saline
Sponsor:   Karadeniz Technical University
Completed - verified June 2015

Venous Thromboembolic Complications in Ovarian Cancer

Conditions:   Venous Thromboembolism;   Ovarian Neoplasms;   Ovarian Cancer;   Deep Vein Thrombosis;   Lung Embolism
Intervention:  
Sponsor:   Aalborg Universitetshospital  
Recruiting - verified May 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified June 2015

Prehospital Tranexamic Acid Use for Traumatic Brain Injury

Condition:   Traumatic Brain Injury
Interventions:   Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI);   U.S. Army Medical Research and Materiel Command;   Canadian Institutes of Health Research  (CIHR);   Heart and Stroke Foundation of Canada;   American Heart Association;   Defence Research and Development Canada
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified June 2015

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified April 2015

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

Conditions:   Deep Venous Thrombosis;   Pulmonary Embolism
Interventions:   Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin
Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Netherlands Organisation for Scientific Research;   Aspen Pharma;   CHU of Saint Etienne (sponsor of the French part of the study)
Recruiting - verified July 2015

Free DNA and Nucleosome Concentrations in Pathological Pregnancies

Conditions:   Pregnancy;   Venous Thrombosis;   Pulmonary Embolism;   Hypertension, Pregnancy-Induced;   Eclampsia;   HELLP Syndrome;   Pre-Eclampsia;   Fetal Death;   Placental Insufficiency
Interventions:   Biological: Bloodwork, baseline;   Biological: Blood work, Months 1 & 2;   Biological: Bloodwork, Months -1 to -6
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Recruiting - verified June 2015

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

The Diagnosis of Occult Deep Vein Thrombosis of the Lower Extremities in Patients Presenting With Hypoxia

Condition:   Hypoxia
Intervention:   Device: Ultrasound compression of femoral and popliteal veins
Sponsor:   HaEmek Medical Center, Israel
Completed - verified June 2015

Venous Thromboembolism in Advanced Gastric Cancer Patients

Condition:   Advanced Gastric Cancer
Intervention:  
Sponsor:   Asan Medical Center
Completed - verified June 2015

Get CardioSmart

You're Invited